Publications

5808 Results

Validation of the association of RECIST changes with survival in men with metastatic castration resistant prostate cancer treated on SWOG study S0421

Authors
G Sonpavde;G Pond;M Plets;C Tangen;M Hussain;P Lara;A Goldkorn;M Garzotto;P Mack;C Higano;N Vogelzang;I Thompson;P Twardowski;P Van Veldhuizen;N Agarwal;M Carducci;JP Monk;DI Quinn
Journal / Conference
Clinical Genitourinary Cancer Dec;15(6):635-641; 2017 May 10 [Epub ahead of print]
Year
2017
Research Committee(s)
Genitourinary
PMID
PMID28579151
PMC
PMC5734863
Study Number(s)
S0421

Randomized phase II study of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG1406)

Authors
ES Kopetz;S McDonough;V Morris;H-J Lenz;A Magliocco;C Atreya;L Diaz;C Allegra;C Lieu;S Wang;SG Eckhardt;T Semrad;K Kaberle;K Guthrie;H Hochster
Journal / Conference
Journal of Clinical Oncology 35, 2017 (suppl 4S; abstract 520); ASCO GI Cancers Symposium (Jan 19-21, 2017, San Francisco, CA), poster, abst.#520
Year
2017
Research Committee(s)
Gastrointestinal
Study Number(s)
S1406

SWOG S1505: a randomized phase II study of peri-operative mFOLFIRINOX vs. gmcitabine/nab-paclitaxel as therapy for resectable pancreatic adenocarcinoma

Authors
D Sohal;S McDonough;S Ahmad;N Gandhi;M Beg;A Wang-Gillam;K Guthrie;A Lowy;P Philip;H Hochster
Journal / Conference
J Clin Oncol 35, 2017 (suppl 4S; abstract TPS508); ASCO GI Cancers Symposium (January 19-21, 2017, San Francisco, CA), poster, abst. #TPS508
Year
2017
Research Committee(s)
Gastrointestinal
Study Number(s)
S1505

Associations of physical activity with survival and progression in metastatic colorectal cancer: results from CALGB 80405 (Alliance)

Authors
B Guercio;A Venook;D Niedzwiecki;S Zhang;K Sato;C Fuchs;H-J Lenz;F Innocenti;B Fruth;E Van Blarigan;B O'Neil;JE Shaw;B Polite;H Hochster;J Atkins;R Goldberg;R Mayer;M Bertagnolli;C Blanke;J Meyerhardt
Journal / Conference
Journal of Clinical Oncology 35, 2017 (suppl 4S; abstract 659); ASCO GI Cancers Symposium (Jan 19-21, 2017, San Francisco, CA), poster, abst.#659
Year
2017
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Association of micropapillary architecture and high tumor budding with prognosis in patients with stage III colon cancer from a FOLFOX-based adjuvant chemotherapy Trial: NCCTG N0147 (Alliance)

Authors
HE Lee;Q Shi;N Foster;DJ Sargent;E Chan;S Gill;M Kahlenberg;S Nair;AF Shields;RM Goldberg;SR Alberts;FA Sinicrope;TC Smyrk
Journal / Conference
Mod Pathol 2017;30(S2):181A; USCAP 2017 Meeting (March 4-10, 2017, San Antonio, TX), poster
Year
2017
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/N0147

Impact of diabetes and insulin use on prognosis in patients resected pancreatic cancer

Authors
TS Hong;KA Winter;CS Fuchs;WF Regine;RA Abrams;H Safran;JP Hoffman;AB Benson;JS MacDonald;TC Kasunic;JF Strauss;T DiPetrillo;PJ Stella;Y Chen;RA Burger;CH Crane
Journal / Conference
J Clin Oncol 35, 2017 (suppl 4S; abstract 369); ASCO GI Cancers Symposium (Jan 19-21, 2017, San Francisco, CA), poster, abst.#369
Year
2017
Research Committee(s)
Gastrointestinal
Study Number(s)
R9704

Adjuvant Androgen Deprivation (ADT) Versus Mitoxantrone Plus Prednisone (MP) Plus ADT in High Risk Prostate Cancer (PCa)Patients Following Radical Prostatectomy: A Phase III Intergroup Trial (SWOG S9921) NCT00004124

Authors
LM Glode;CM Tangen;M Hussain;GP Swanson;DP Wood;W Sakr;NA Dawson;NB Haas;TW Flaig;TB Dorff;DW Lin;ED Crawford;DI Quinn;NJ Vogelzang;IM Thompson
Journal / Conference
Journal of Clinical Oncology 35, 2017(suppl 6S; abstract 2); ASCO GU Cancers Symposium (February16-18, 2017, Orlando, FL), oral
Year
2017
Research Committee(s)
Genitourinary
Study Number(s)
S9921

Impact of metformin on overall and prostate cancer-specific survival in the chemohormonal adjuvant chemotherapy CHAARTED trial (http://meetinglibrary.asco.org/content/179540-197)

Authors
D Jarrard;YH Chen;G Liu;M Carducci;M Eisenberger;YN Wong;L Patrick-Miller;N Hahn;M Kohli;M Cooney;R Dreicer;NJ Vogelzang;J Picus;D Shevrin;M Hussain;J Garcia;R Dipaola;C Sweeney
Journal / Conference
Journal of Clinical Oncology 35, 2017 (suppl 6S; abstract 181); ASCO GU Cancers Symposium (February16-18, 2017, Orlando, FL), poster
Year
2017
Research Committee(s)
Genitourinary
Study Number(s)
CTSU/E3805

Steroid hormone receptor protein expression by gender and smoking in non-small cell lung cancer:SWOG S0424

Authors
T-Y Cheng;A Darke;M Redman;G Zirpoli;W Davis;R Payne Ondracek;W Bshara;R Kratzke;JR Molina;JM Molina;Y Chen;RM MacRae;J Moon;P Mack;D Gandara;K Kelly;R Santella;KS Albain;C Ambrosone
Journal / Conference
Modern Pathology Vol 30, Issue S2 (February 2017), p. 474A, abst. 1907; USCAP Annual Meeting 2017 (March 4-10, 2017, San Antonio, TX), poster
Year
2017
Research Committee(s)
Lung
Study Number(s)
S0424

Consistency of standing orders for primary prophylactic CSF within a national network of community oncology practices: SWOG Intergroup Trial S1415CD

Authors
S Ramsey;DL Hershman;A Bell-Brown;K Watabayashi;K Kreizenbeck;S Sullivan;A Bansal;W Barlow;K Arnold;G Lyman
Journal / Conference
AACR Annual Meeting 2017 (April 1-5, 2017, Washington, DC), poster, abst. 2767/ 7
Year
2017
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S1415CD